Relation Between Chemokine Receptor Use, Disease Stage, and HIV-1 Subtypes A and D

Abstract

These subtype differences in coreceptor use may partially explain the faster progression rates we have previously reported in individuals infected with subtype D compared with subtype A. Our observations may have implications for the future use of coreceptor inhibitors in this population.